版本:
中国

BRIEF-Coherus says completes two pharmacokinetic bioequivalence studies of CHS-0214

Oct 6 Coherus Biosciences

* Says completes two pharmacokinetic bioequivalence studies of CHS-0214

* Moving forward with pre-submission meetings, now expected in Q1 2017, to review complete CHS-0214 program prior to filing

* CHS-0214-06 study achieved primary PK BE endpoint Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐